| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2403900C Substituted chalcones as therapeutic compounds |
| 02/08/2011 | CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 02/08/2011 | CA2369588C Anticancer calcium channel blockers |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/08/2011 | CA2350207C T cells specific for target antigens and methods and vaccines based thereon |
| 02/08/2011 | CA2341574C Phosphohalohydrins, method for making same and uses |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2273825C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 02/08/2011 | CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/04/2011 | CA2710224A1 Novel dihydroindolone derivatives, method for production thereof and pharmaceutical compositions comprising said derivatives |
| 02/03/2011 | WO2011014872A2 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 02/03/2011 | WO2011014863A2 Prophylaxis against cancer metastasis |
| 02/03/2011 | WO2011014825A2 Antiangiogenic small molecules and methods of use |
| 02/03/2011 | WO2011014817A1 Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors |
| 02/03/2011 | WO2011014766A2 Crystallization method and bioavailability |
| 02/03/2011 | WO2011014750A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | WO2011014681A1 Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS |
| 02/03/2011 | WO2011014661A2 Liver x receptor agonists |
| 02/03/2011 | WO2011014515A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors |
| 02/03/2011 | WO2011014469A1 High affinity human antibodies to human angiopoietin-2 |
| 02/03/2011 | WO2011014261A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | WO2011014248A1 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
| 02/03/2011 | WO2011014128A1 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity |
| 02/03/2011 | WO2011014009A2 Novel di-substituted phenoxyacetyl-based compound or pharmaceutically acceptable salt thereof, production method for same and pharmaceutical composition for suppressing multiple drug resistance comprising same as an active ingredient |
| 02/03/2011 | WO2011013912A2 Pharmaceutical composition for enhancing radiation therapy for cancer, and method for screening active material for enhancing radiation therapy for cancer |
| 02/03/2011 | WO2011013786A1 Cancer metastasis inhibitor |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013729A1 Fused imidazole derivative having ttk inhibitory action |
| 02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013656A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | WO2011013612A1 Peptidic compound and use of same |
| 02/03/2011 | WO2011013358A1 Anti-tumor agent |
| 02/03/2011 | WO2011013159A1 Photochemotherapeutic heterocyclic agents having antiproliferative and antineoplastic activity |
| 02/03/2011 | WO2011013108A1 Polymorphic form of toremifene citrate and process for its preparation |
| 02/03/2011 | WO2011013002A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | WO2011012885A1 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer |
| 02/03/2011 | WO2011012883A1 Benzo [e] [1, 3 ] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors |
| 02/03/2011 | WO2011012816A2 Pharmaceutical formulation |
| 02/03/2011 | WO2011012698A2 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 02/03/2011 | WO2011012661A1 Pyridine and pyrazine derivatives as protein kinase modulators |
| 02/03/2011 | WO2011012660A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process |
| 02/03/2011 | WO2011012585A1 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity |
| 02/03/2011 | WO2011012577A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases |
| 02/03/2011 | WO2011012534A1 Plk inhibitor salts |
| 02/03/2011 | WO2011012312A1 Bladder instillation compositions for treating bladder cancer |
| 02/03/2011 | WO2011011984A1 Sterol derivatives and their synthesis and use |
| 02/03/2011 | WO2011011976A1 Homing peptide for tumor vasculature |
| 02/03/2011 | WO2011011973A1 Fusion protein of anti-cd20 antibody fab fragment and lidamycin, preparation method and use thereof |
| 02/03/2011 | WO2011011965A1 Luteinising hormone releasing hormone antagonist with hydantoin structure |
| 02/03/2011 | WO2011011882A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | WO2011011865A1 Anticancer agents based on amino acid derivatives |
| 02/03/2011 | WO2010123545A3 Angiogenesis inhibitors |
| 02/03/2011 | WO2010102281A3 Inhibitors of anaphase promoting complex activity |
| 02/03/2011 | WO2010091193A3 Triptolide c-ring derivatives as anticancer agents and immune modulators |
| 02/03/2011 | WO2010065961A3 Compositions and methods relating to mir-31 |
| 02/03/2011 | WO2010060937A3 Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor |
| 02/03/2011 | WO2010059969A8 Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer |
| 02/03/2011 | WO2009132238A3 Ido inhibitors |
| 02/03/2011 | US20110030074 Compositions and methods for cancer gene discovery |
| 02/03/2011 | US20110028807 Contact lens for collecting tears and detecting at least one analyte |
| 02/03/2011 | US20110028543 Formulations and methods of using nitric oxide mimetics in cancer treatment |
| 02/03/2011 | US20110028542 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 02/03/2011 | US20110028540 Synthesis of macrocyclic cancer chemotherapy agents and methods of use |
| 02/03/2011 | US20110028539 Biologically active taxane analogs and methods of treatment |
| 02/03/2011 | US20110028536 Methods and compositions for topoisomerase i modulated tumor suppression |
| 02/03/2011 | US20110028533 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/03/2011 | US20110028514 Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 02/03/2011 | US20110028498 Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase |
| 02/03/2011 | US20110028497 Novel derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents |
| 02/03/2011 | US20110028492 Heteroaryl Compounds and Their Uses |
| 02/03/2011 | US20110028488 Combination product comprising src kinase inhibitor azdo530 and an antioestrogen or egfr-tk-inhibitor |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
| 02/03/2011 | US20110028473 Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives |
| 02/03/2011 | US20110028472 Thienopyrimidines |
| 02/03/2011 | US20110028471 Combination therapy 238 |
| 02/03/2011 | US20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028458 Inhibition of cell migration by a farnesylated dibenzodiazepinone |
| 02/03/2011 | US20110028452 PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS |
| 02/03/2011 | US20110028449 Novel aminomethyl benzene derivatives |
| 02/03/2011 | US20110028448 Pyridine compounds |
| 02/03/2011 | US20110028439 Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer |
| 02/03/2011 | US20110028435 Crystallization method and bioavailability |
| 02/03/2011 | US20110028433 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 02/03/2011 | US20110028431 Oral mucoadhesive dosage form |
| 02/03/2011 | US20110028422 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia |
| 02/03/2011 | US20110028421 Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 02/03/2011 | US20110028415 Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukenia management |
| 02/03/2011 | US20110028411 Alpha-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110028400 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/03/2011 | US20110028395 Peptide modulators of angiogenesis and use thereof |
| 02/03/2011 | US20110028384 Rap variants for drug delivery |